CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

clinical trial

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00211939

P6099clinical trial phasephase IV clinical trialQ42825046
P17countryUnited States of AmericaQ30
P582end time2006-12-01
P1050medical conditionarteriosclerosisQ184559
hyperparathyroidismQ1344835
calcinosisQ239027
P2899minimum age18
P1132number of participants203
P4844research interventioncalcium oxalateQ412399
sevelamerQ904153
P859sponsorNabi BiopharmaceuticalsQ6956843
P580start time2005-01-01
P8363study typeinterventional studyQ78089383
P1476titleCARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2)

Search more.